Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Itraconazole inhalation - Laboratoires SMB

Next Previous
Search
Drug Profile

Itraconazole inhalation - Laboratoires SMB

Alternative Names: ITZ DPI

Latest Information Update: 17 Aug 2022

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Laboratoires SMB
  • Class Antiasthmatics; Antifungals; Antineoplastics; Azoles; Chlorobenzenes; Dioxoles; Piperazines; Small molecules; Triazoles
  • Mechanism of Action 14-alpha demethylase inhibitors; Cytochrome P-450 enzyme system inhibitors; Hedgehog cell signalling pathway inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase III Mycoses

Most Recent Events

  • 17 Aug 2022 EudraCT2019-002408-42 - trial info updated
  • 28 Jun 2022 Laboratoires SMB completes a phase III trial in Mycoses (In adolescents, In adults, In the elderly, Prevention) in Belgium, Greece, Romania, Italy, Spain, Poland and Bulgaria (Inhalation) (EudraCT2019-002408-42)
  • 13 Mar 2020 Chemical structure information added

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top